Literature DB >> 29312694

A big data approach to examine the association of high density lipoprotein cholesterol and mortality: lessons for future investigations.

Ziyad Al-Aly1,2,3,4.   

Abstract

Year:  2017        PMID: 29312694      PMCID: PMC5757036          DOI: 10.21037/jtd.2017.11.95

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  13 in total

1.  Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Yan Yan; Ziyad Al-Aly
Journal:  Kidney Int       Date:  2017-02-22       Impact factor: 10.612

2.  High density lipoprotein cholesterol and risk of death.

Authors:  Ziyad Al-Aly
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways.

Authors:  Chun-Yao Huang; Feng-Yen Lin; Chun-Ming Shih; Heng-Kien Au; Yu-Jia Chang; Hironori Nakagami; Ryuichi Morishita; Nen-Chung Chang; Kou-Gi Shyu; Jaw-Wen Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-16       Impact factor: 8.311

4.  High density lipoprotein cholesterol and mortality. The Framingham Heart Study.

Authors:  P W Wilson; R D Abbott; W P Castelli
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

5.  Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD.

Authors:  Benjamin Bowe; Yan Xie; Tingting Li; Yan Yan; Hong Xian; Ziyad Al-Aly
Journal:  J Am Soc Nephrol       Date:  2017-09-21       Impact factor: 10.121

6.  High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.

Authors:  Dennis T Ko; David A Alter; Helen Guo; Maria Koh; Geoffrey Lau; Peter C Austin; Gillian L Booth; William Hogg; Cynthia A Jackevicius; Douglas S Lee; Harindra C Wijeysundera; John T Wilkins; Jack V Tu
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

7.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245

8.  High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans.

Authors:  Benjamin Bowe; Yan Xie; Hong Xian; Sumitra Balasubramanian; Mohamed A Zayed; Ziyad Al-Aly
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 8.237

9.  Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.

Authors:  Christian M Madsen; Anette Varbo; Børge G Nordestgaard
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

10.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Authors:  Benjamin F Voight; Gina M Peloso; Marju Orho-Melander; Ruth Frikke-Schmidt; Maja Barbalic; Majken K Jensen; George Hindy; Hilma Hólm; Eric L Ding; Toby Johnson; Heribert Schunkert; Nilesh J Samani; Robert Clarke; Jemma C Hopewell; John F Thompson; Mingyao Li; Gudmar Thorleifsson; Christopher Newton-Cheh; Kiran Musunuru; James P Pirruccello; Danish Saleheen; Li Chen; Alexandre F R Stewart; Arne Schillert; Unnur Thorsteinsdottir; Gudmundur Thorgeirsson; Sonia Anand; James C Engert; Thomas Morgan; John Spertus; Monika Stoll; Klaus Berger; Nicola Martinelli; Domenico Girelli; Pascal P McKeown; Christopher C Patterson; Stephen E Epstein; Joseph Devaney; Mary-Susan Burnett; Vincent Mooser; Samuli Ripatti; Ida Surakka; Markku S Nieminen; Juha Sinisalo; Marja-Liisa Lokki; Markus Perola; Aki Havulinna; Ulf de Faire; Bruna Gigante; Erik Ingelsson; Tanja Zeller; Philipp Wild; Paul I W de Bakker; Olaf H Klungel; Anke-Hilse Maitland-van der Zee; Bas J M Peters; Anthonius de Boer; Diederick E Grobbee; Pieter W Kamphuisen; Vera H M Deneer; Clara C Elbers; N Charlotte Onland-Moret; Marten H Hofker; Cisca Wijmenga; W M Monique Verschuren; Jolanda M A Boer; Yvonne T van der Schouw; Asif Rasheed; Philippe Frossard; Serkalem Demissie; Cristen Willer; Ron Do; Jose M Ordovas; Gonçalo R Abecasis; Michael Boehnke; Karen L Mohlke; Mark J Daly; Candace Guiducci; Noël P Burtt; Aarti Surti; Elena Gonzalez; Shaun Purcell; Stacey Gabriel; Jaume Marrugat; John Peden; Jeanette Erdmann; Patrick Diemert; Christina Willenborg; Inke R König; Marcus Fischer; Christian Hengstenberg; Andreas Ziegler; Ian Buysschaert; Diether Lambrechts; Frans Van de Werf; Keith A Fox; Nour Eddine El Mokhtari; Diana Rubin; Jürgen Schrezenmeir; Stefan Schreiber; Arne Schäfer; John Danesh; Stefan Blankenberg; Robert Roberts; Ruth McPherson; Hugh Watkins; Alistair S Hall; Kim Overvad; Eric Rimm; Eric Boerwinkle; Anne Tybjaerg-Hansen; L Adrienne Cupples; Muredach P Reilly; Olle Melander; Pier M Mannucci; Diego Ardissino; David Siscovick; Roberto Elosua; Kari Stefansson; Christopher J O'Donnell; Veikko Salomaa; Daniel J Rader; Leena Peltonen; Stephen M Schwartz; David Altshuler; Sekar Kathiresan
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.